Highland Capital Management Fund Advisors, L.P. Next Cure, Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

  • $865 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.7 - $9.1 $1.24 Million - $1.98 Million
-217,139 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$6.74 - $8.02 $118,415 - $140,903
-17,569 Reduced 7.49%
217,139 $1.46 Million
Q2 2021

Aug 16, 2021
BUY
$7.6 - $10.28 $1.78 Million - $2.41 Million
234,708 New
234,708 $1.89 Million
Q2 2020

Aug 14, 2020
SELL
$21.19 - $40.2 $158,925 - $301,500
-7,500 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$25.0 - $92.22 $187,500 - $691,650
7,500 New
7,500 $422,000

Others Institutions Holding NXTC

# of Institutions
45
Shares Held
14.6M
Call Options Held
0
Put Options Held
0
View Full List

About NextCure, Inc.

NXTC Quotes by TradingView
  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $20.8M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Highland Capital Management Fund Advisors, L.P. Portfolio

Follow Highland Capital Management Fund Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email